Cite
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients
MLA
Lucy R. Wedderburn, et al. “Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.” The Journal of Rheumatology, vol. 44, no. 4, Dec. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b9f721456f2d61952176b4a8020c444&authtype=sso&custid=ns315887.
APA
Lucy R. Wedderburn, Stefania Simou, Mark Wood, Kishore Warrier, Thomas S. Jacques, Neil McHugh, Zoe E Betteridge, Sarah L Tansley, & Clarissa Pilkington. (2016). Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. The Journal of Rheumatology, 44(4).
Chicago
Lucy R. Wedderburn, Stefania Simou, Mark Wood, Kishore Warrier, Thomas S. Jacques, Neil McHugh, Zoe E Betteridge, Sarah L Tansley, and Clarissa Pilkington. 2016. “Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.” The Journal of Rheumatology 44 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b9f721456f2d61952176b4a8020c444&authtype=sso&custid=ns315887.